VAVGJ
DeviceReplacement of the aortic valve and ascending aorta
NCT Number: NCT04754217
Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Klinik Floridsdorf, Vienna, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Replacement of the aortic valve and ascending aorta
Replacement of the aortic valve and ascending aorta
Time frame: 5 Years
Primary Safety Endpoint
Time frame: 5 Years
Primary Effectiveness Endpoint
Contact information is provided by the study sponsor or research team.
Karine Miquel
CONTACT
Paolo Amato
CONTACT
Abbott Medical Devices
Industry
Valved Graft Post-Market Clinical Follow-up Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07619872
Aortic Valve Disease, Cardiovascular Diseases
München, Bavaria, Germany
View Trial DetailsNCT07276711
Aortic Stenosis, Aortic Valve Disease
New Orleans, Louisiana, United States
View Trial DetailsNCT07120048
Aortic Valve Disease, Cardiovascular Diseases
Heidelberg, Baden-Wurttemberg, Germany
View Trial DetailsNCT06286358
Aneurysm, Aortic Aneurysm
Brussels, Belgium
View Trial Details